And despite one patient being admitted to the hospital while utilizing the artificial pancreas, this was due to an abscess located at the site of the pump cannula.
So now, the study’s co-leader, Dr. Charlotte Boughton, is confident that the new device is an extremely viable treatment option for type 2 diabetes patients.
“One of the barriers to widespread use of insulin therapy has been concern over the risk of severe ‘hypos’– dangerously low blood sugar levels,” she explained.
“But we found that no patients on our trial experience these, and patients spent very little time with blood sugar levels lower than the target levels.”
The team’s next step is to conduct an even larger multicenter study to expand their findings. The researchers have also submitted the artificial pancreas for regulatory approval with the goal of making it commercially available for type 2 diabetes outpatients.
To read the study’s complete findings, which have since been published in Nature Medicine, visit the link here.
If true crime defines your free time, this is for you: join Chip Chick’s True Crime Tribe